☆ 4.5 Article

Home systolic blood pressure time in therapeutic range and cardiovascular risk: the practitioner-based nationwide J-HOP study extended

HYPERTENSION RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Peripheral Vascular Disease

Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events

Leo F. Buckley et al.

Summary: The study found that the amount of time spent within the target range for blood pressure is associated with adverse kidney and cardiovascular events. Better blood pressure control in hypertensive patients is linked to a lower risk of kidney and cardiovascular problems.

HYPERTENSION (2023)

Add to Collection

Review Peripheral Vascular Disease

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Barbara Citoni et al.

Summary: Hypertension is a common cardiovascular risk factor, but awareness remains low with many patients undiagnosed and at risk of acute cardiovascular events. Home BP monitoring is shown to be one of the most effective interventions, improving patients' understanding of the disease and adherence to medications. Telemedicine during the COVID-19 pandemic has proven to be a valuable tool for managing hypertension and other conditions.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range

Felix Mahfoud et al.

Summary: This study aimed to evaluate the impact of radiofrequency renal denervation (RDN) on time in therapeutic range (TTR) and its association with cardiovascular outcomes. The results showed sustained blood pressure reductions and higher TTR through 36 months after RDN. A 10% increase in TTR through 6 months was associated with significant risk reductions in major cardiovascular events from 6 to 36 months.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of Systolic Blood Pressure Time in Target Range on Adverse Events in Patients With Nonvalvular Atrial Fibrillation (from the J-RHYTHM Registry)

Eitaro Kodani et al.

Summary: This study found that time in target range (TTR) of systolic blood pressure in patients with non-valvular atrial fibrillation (NVAF) is associated with the risk of cardiovascular death, while time in subtarget range of blood pressure is associated with the risk of thromboembolism. These indicators can be useful tools for patient risk assessment.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Review Peripheral Vascular Disease

Digital Therapeutics in Hypertension: Evidence and Perspectives

Kazuomi Kario et al.

Summary: Digital therapeutics involves the use of evidence-based therapeutic interventions driven by software programs. It can aid in managing hypertension and improving lifestyle modifications and medication adherence. However, further research is needed to develop more feasible strategies and evaluate them in clinical trials.

HYPERTENSION (2022)

Add to Collection

Article Peripheral Vascular Disease

Blood pressure control measures and cardiovascular outcomes: a prospective hypertensive cohort

Konstantinos Sideris et al.

Summary: This study investigated the association between blood pressure control measures, visit-to-visit blood pressure variability, and time in therapeutic range (TTR) with future cardiovascular outcomes in hypertensive patients. The results showed that high blood pressure variability and low TTR were associated with increased risk of cardiovascular events, and the significance of TTR appeared to be greater than blood pressure variability in predicting outcomes.

BLOOD PRESSURE (2022)

Add to Collection

Review Peripheral Vascular Disease

The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice

Kazuomi Kario et al.

Summary: The HERB-DH1 trial in 2021 demonstrated the effectiveness of hypertension digital therapeutics in reducing blood pressure for patients with hypertension. The approval and insurance coverage in Japan further validate its clinical significance, making it a widely applicable solution for the management of hypertension.

HYPERTENSION RESEARCH (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Range and Cardiovascular Outcomes in Patients With Hypertension

Nayyra Fatani et al.

Summary: The study found an independent association between time in systolic blood pressure target range and major adverse cardiovascular events among adults with hypertension. Each 1-SD increase in time in target range was significantly associated with a decreased risk of first major adverse cardiovascular event.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis

Denis Pouchain

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial

Kazuomi Kario et al.

Summary: The study investigated the efficacy of digital therapeutics in patients with hypertension not receiving antihypertensive medication. The results showed significant reductions in 24-hour ambulatory, home, and office systolic blood pressure in the digital therapeutics group at 12 weeks, with no major safety events reported.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Kazem Rahimi et al.

Summary: A meta-analysis of randomized controlled trials found that pharmacological blood pressure reduction can reduce the risk of cardiovascular events in the elderly, with no variation in relative risk reduction based on age and baseline blood pressure levels, and greater absolute risk reductions in older age groups.

LANCET (2021)

Add to Collection

Article Peripheral Vascular Disease

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Satoshi Umemura et al.

HYPERTENSION RESEARCH (2019)

Add to Collection

Article Peripheral Vascular Disease

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Paul K. Whelton et al.

HYPERTENSION (2018)

Add to Collection

Article Peripheral Vascular Disease

Home blood pressure telemonitoring in the 21st century

Gianfranco Parati et al.

JOURNAL OF CLINICAL HYPERTENSION (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension

Michael Doumas et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

Add to Collection

Editorial Material Medicine, General & Internal

Systolic pressure is all that matters

Bryan Williams et al.

LANCET (2008)

Add to Collection

Article Peripheral Vascular Disease

Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home

Y Imai et al.

HYPERTENSION RESEARCH (2003)

Add to Collection

Article Peripheral Vascular Disease

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives - Analysis based on National Health and Nutrition Examination Survey (NHANES) III

SS Franklin et al.

HYPERTENSION (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.